{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:15:28Z","timestamp":1772608528822,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T00:00:00Z","timestamp":1429660800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12985-015-0295-3","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T03:34:01Z","timestamp":1429587241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding"],"prefix":"10.1186","volume":"12","author":[{"given":"Peter G","family":"Mohr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Mo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L","family":"McKimm-Breschkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,22]]},"reference":[{"issue":"37","key":"295_CR1","doi-asserted-by":"publisher","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","volume":"285","author":"SJ Gamblin","year":"2010","unstructured":"Gamblin SJ, Skehel JJ. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem. 2010;285(37):28403\u20139.","journal-title":"J Biol Chem"},{"key":"295_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000;69:531\u201369.","journal-title":"Annu Rev Biochem"},{"issue":"3\u20134","key":"295_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF01313781","volume":"133","author":"IA Rudneva","year":"1993","unstructured":"Rudneva IA, Kovaleva VP, Varich NL, Farashyan VR, Gubareva LV, Yamnikova SS, et al. Influenza A virus reassortants with surface glycoprotein genes of the avian parent viruses: effects of HA and NA gene combinations on virus aggregation. Arch Virol. 1993;133(3\u20134):437\u201350.","journal-title":"Arch Virol"},{"issue":"22","key":"295_CR4","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","volume":"78","author":"MN Matrosovich","year":"2004","unstructured":"Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol. 2004;78(22):12665\u20137.","journal-title":"J Virol"},{"key":"295_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/1743-422X-10-321","volume":"10","author":"M Cohen","year":"2013","unstructured":"Cohen M, Zhang XQ, Senaati HP, Chen HW, Varki NM, Schooley RT, et al. Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase. Virol J. 2013;10:321.","journal-title":"Virol J"},{"key":"295_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/1743-422X-8-411","volume":"8","author":"H Ushirogawa","year":"2011","unstructured":"Ushirogawa H, Ohuchi M. Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus. Virol J. 2011;8:411.","journal-title":"Virol J"},{"issue":"22","key":"295_CR7","doi-asserted-by":"publisher","first-page":"11808","DOI":"10.1073\/pnas.94.22.11808","volume":"94","author":"JN Varghese","year":"1997","unstructured":"Varghese JN, Colman PM, Van Donkelaar A, Blick TJ, Sahasrabudhe A, McKimm-Breschkin JL. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases. Proc Natl Acad Sci U S A. 1997;94(22):11808\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"295_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/0042-6822(91)90979-L","volume":"183","author":"JM Nuss","year":"1991","unstructured":"Nuss JM, Air GM. Transfer of the hemagglutinin activity of influenza virus neuraminidase subtype N9 into an N2 neuraminidase background. Virology. 1991;183(2):496\u2013504.","journal-title":"Virology"},{"issue":"13","key":"295_CR9","doi-asserted-by":"publisher","first-page":"6769","DOI":"10.1128\/JVI.00458-10","volume":"84","author":"YP Lin","year":"2010","unstructured":"Lin YP, Gregory V, Collins P, Kloess J, Wharton S, Cattle N, et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol. 2010;84(13):6769\u201381.","journal-title":"J Virol"},{"issue":"24","key":"295_CR10","doi-asserted-by":"publisher","first-page":"13371","DOI":"10.1128\/JVI.01426-12","volume":"86","author":"X Zhu","year":"2012","unstructured":"Zhu X, McBride R, Nycholat CM, Yu W, Paulson JC, Wilson IA. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors. J Virol. 2012;86(24):13371\u201383.","journal-title":"J Virol"},{"issue":"6","key":"295_CR11","doi-asserted-by":"publisher","first-page":"e66325","DOI":"10.1371\/journal.pone.0066325","volume":"8","author":"S Gulati","year":"2013","unstructured":"Gulati S, Smith DF, Cummings RD, Couch RB, Griesemer SB, St George K, et al. Human H3N2 influenza viruses isolated from 1968 to 2012 show varying preference for receptor substructures with no apparent consequences for disease or spread. PLoS One. 2013;8(6):e66325.","journal-title":"PLoS One"},{"issue":"6428","key":"295_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"M Von Itzstein","year":"1993","unstructured":"Von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 1993;363(6428):418\u201323.","journal-title":"Nature"},{"issue":"13","key":"295_CR13","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1128\/JVI.74.13.6015-6020.2000","volume":"74","author":"LJ Mitnaul","year":"2000","unstructured":"Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, et al. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol. 2000;74(13):6015\u201320.","journal-title":"J Virol"},{"issue":"1","key":"295_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1006\/viro.1998.9194","volume":"246","author":"TJ Blick","year":"1998","unstructured":"Blick TJ, Sahasrabudhe A, McDonald M, Owens IJ, Morley PJ, Fenton RJ, et al. The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en. Virology. 1998;246(1):95\u2013103.","journal-title":"Virology"},{"issue":"1","key":"295_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.40.1.40","volume":"40","author":"JL McKimm-Breschkin","year":"1996","unstructured":"McKimm-Breschkin JL, Blick TJ, Sahasrabudhe A, Tiong T, Marshall D, Hart GJ, et al. Generation and characterization of variants of NWS\/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. Antimicrob Agents Chemother. 1996;40(1):40\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 6","key":"295_CR16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1099\/0022-1317-79-6-1405","volume":"79","author":"A Grassauer","year":"1998","unstructured":"Grassauer A, Egorov AY, Ferko B, Romanova I, Katinger H, Muster T. A host restriction-based selection system for influenza haemagglutinin transfectant viruses. J Gen Virol. 1998;79(Pt 6):1405\u20139.","journal-title":"J Gen Virol"},{"issue":"1","key":"295_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/viro.2001.1121","volume":"289","author":"R Medeiros","year":"2001","unstructured":"Medeiros R, Escriou N, Naffakh N, Manuguerra JC, Van der Werf S. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology. 2001;289(1):74\u201385.","journal-title":"Virology"},{"issue":"44\u201346","key":"295_CR18","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1016\/j.vaccine.2006.05.062","volume":"24","author":"B Lu","year":"2006","unstructured":"Lu B, Zhou H, Chan W, Kemble G, Jin H. Single amino acid substitutions in the hemagglutinin of influenza A\/Singapore\/21\/04 (H3N2) increase virus growth in embryonated chicken eggs. Vaccine. 2006;24(44\u201346):6691\u20133.","journal-title":"Vaccine"},{"issue":"2","key":"295_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0042-6822(03)00377-5","volume":"313","author":"L Mochalova","year":"2003","unstructured":"Mochalova L, Gambaryan A, Romanova J, Tuzikov A, Chinarev A, Katinger D, et al. Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology. 2003;313(2):473\u201380.","journal-title":"Virology"},{"issue":"22","key":"295_CR20","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1016\/j.vaccine.2009.02.064","volume":"27","author":"PD Minor","year":"2009","unstructured":"Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, Colegate T, et al. Current challenges in implementing cell-derived influenza vaccines: Implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. Vaccine. 2009;27(22):2907\u201313.","journal-title":"Vaccine"},{"issue":"2","key":"295_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1006\/viro.1998.9224","volume":"247","author":"AS Gambaryan","year":"1998","unstructured":"Gambaryan AS, Marinina VP, Tuzikov AB, Bovin NV, Rudneva IA, Sinitsyn BV, et al. Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties of H1N1 human influenza a virus grown in MDCK cells and in embryonated eggs. Virology. 1998;247(2):170\u20137.","journal-title":"Virology"},{"issue":"20","key":"295_CR22","doi-asserted-by":"publisher","first-page":"11170","DOI":"10.1128\/JVI.01217-07","volume":"81","author":"RE Owen","year":"2007","unstructured":"Owen RE, Yamada E, Thompson CI, Phillipson LJ, Thompson C, Taylor E, et al. Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J Virol. 2007;81(20):11170\u20138.","journal-title":"J Virol"},{"key":"295_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1743-422X-4-42","volume":"4","author":"K Kumari","year":"2007","unstructured":"Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, Air GM. Receptor binding specificity of recent human H3N2 influenza viruses. Virol J. 2007;4:42.","journal-title":"Virol J"},{"issue":"16","key":"295_CR24","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1128\/JVI.00058-10","volume":"84","author":"J Stevens","year":"2010","unstructured":"Stevens J, Chen LM, Carney PJ, Garten R, Foust A, Le J, et al. Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs. J Virol. 2010;84(16):8287\u201399.","journal-title":"J Virol"},{"issue":"12","key":"295_CR25","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1128\/AAC.01364-13","volume":"57","author":"D Tamura","year":"2013","unstructured":"Tamura D, Nguyen HT, Sleeman K, Levine M, Mishin VP, Yang H, et al. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment. Antimicrob Agents Chemother. 2013;57(12):6141\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"295_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0042-6822(91)90588-3","volume":"182","author":"E Nobusawa","year":"1991","unstructured":"Nobusawa E, Aoyama T, Kato H, Suzuki Y, Tateno Y, Nakajima K. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology. 1991;182(2):475\u201385.","journal-title":"Virology"},{"issue":"3","key":"295_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.antiviral.2013.06.003","volume":"99","author":"C Dapat","year":"2013","unstructured":"Dapat C, Kondo H, Dapat IC, Baranovich T, Suzuki Y, Shobugawa Y, et al. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009\u20132010 and 2010\u20132011 influenza seasons in Japan. Antiviral Res. 2013;99(3):261\u20139.","journal-title":"Antiviral Res"},{"key":"295_CR28","first-page":"93","volume":"101C","author":"VP Mishin","year":"2013","unstructured":"Mishin VP, Sleeman K, Levine M, Carney PJ, Stevens J, Gubareva LV. The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses. Antiviral Res. 2013;101C:93\u20136.","journal-title":"Antiviral Res"},{"issue":"6","key":"295_CR29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3851\/IMP1194","volume":"14","author":"M Tashiro","year":"2009","unstructured":"Tashiro M, McKimm-Breschkin JL, Saito T, Klimov A, Macken C, Zambon M, et al. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996\u20132007. Antivir Ther. 2009;14(6):751\u201361.","journal-title":"Antivir Ther"},{"issue":"6128","key":"295_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1126\/science.1232552","volume":"340","author":"JH Kim","year":"2013","unstructured":"Kim JH, Resende R, Wennekes T, Chen HM, Bance N, Buchini S, et al. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity. Science. 2013;340(6128):71\u20135.","journal-title":"Science"},{"issue":"23","key":"295_CR31","doi-asserted-by":"publisher","first-page":"12531","DOI":"10.1128\/JVI.01889-13","volume":"87","author":"KA Hooper","year":"2013","unstructured":"Hooper KA, Bloom JD. A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein. J Virol. 2013;87(23):12531\u201340.","journal-title":"J Virol"},{"issue":"7","key":"295_CR32","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1128\/JVI.00012-15","volume":"89","author":"KA Hooper","year":"2015","unstructured":"Hooper KA, Crowe Jr JE, Bloom JD. Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice. J Virol. 2015;89(7):3737\u201345.","journal-title":"J Virol"},{"issue":"17","key":"295_CR33","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1021\/jm100621s","volume":"53","author":"AJ Oakley","year":"2010","unstructured":"Oakley AJ, Barrett S, Peat TS, Newman J, Streltsov VA, Waddington L, et al. Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses. J Med Chem. 2010;53(17):6421\u201331.","journal-title":"J Med Chem"},{"issue":"18","key":"295_CR34","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.vaccine.2015.03.009","volume":"33","author":"YV Liu","year":"2015","unstructured":"Liu YV, Massare MJ, Pearce MB, Sun X, Belser JA, Maines TR, et al. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets. Vaccine. 2015;33(18):2152\u20138.","journal-title":"Vaccine"},{"issue":"20","key":"295_CR35","doi-asserted-by":"publisher","first-page":"10905","DOI":"10.1128\/JVI.00700-11","volume":"85","author":"JC Krause","year":"2011","unstructured":"Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Basler CF, Crowe Jr JE. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J Virol. 2011;85(20):10905\u20138.","journal-title":"J Virol"},{"issue":"11","key":"295_CR36","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1128\/JVI.00469-12","volume":"86","author":"GS Tan","year":"2012","unstructured":"Tan GS, Krammer F, Eggink D, Kongchanagul A, Moran TM, Palese P. A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo. J Virol. 2012;86(11):6179\u201388.","journal-title":"J Virol"},{"issue":"4","key":"295_CR37","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.bbrc.2010.02.031","volume":"393","author":"A Yamashita","year":"2010","unstructured":"Yamashita A, Kawashita N, Kubota-Koketsu R, Inoue Y, Watanabe Y, Ibrahim MS, et al. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition. Biochem Biophys Res Commun. 2010;393(4):614\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"295_CR38","doi-asserted-by":"publisher","first-page":"e1000350","DOI":"10.1371\/journal.ppat.1000350","volume":"5","author":"R Yoshida","year":"2009","unstructured":"Yoshida R, Igarashi M, Ozaki H, Kishida N, Tomabechi D, Kida H, et al. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog. 2009;5(3):e1000350.","journal-title":"PLoS Pathog"},{"issue":"1","key":"295_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.antiviral.2011.04.010","volume":"91","author":"PG Mohr","year":"2011","unstructured":"Mohr PG, Geyer H, McKimm-Breschkin JL. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors. Antiviral Res. 2011;91(1):20\u20132.","journal-title":"Antiviral Res"},{"issue":"7","key":"295_CR40","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1128\/AAC.01339-05","volume":"50","author":"AS Monto","year":"2006","unstructured":"Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3\u00a0years of their use. Antimicrob Agents Chemother. 2006;50(7):2395\u2013402.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"295_CR41","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1128\/AAC.50.5.1872-1874.2006","volume":"50","author":"AC Hurt","year":"2006","unstructured":"Hurt AC, Iannello P, Jachno K, Komadina N, Hampson AW, Barr IG, et al. Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient. Antimicrob Agents Chemother. 2006;50(5):1872\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"295_CR42","unstructured":"Manual of diagnostic tests and vaccines for terrestrial animals 2009. Avian influenza [http:\/\/www.oie.int\/fileadmin\/Home\/eng\/Health_standards\/tahm\/2.03.04_AI.pdf]"},{"issue":"2","key":"295_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","volume":"94","author":"M Potier","year":"1979","unstructured":"Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. Fluorometric assay of neuraminidase with a sodium (4-Methylumbelliferyl-Alpha-D-N-Acetylneuraminate) substrate. Anal Biochem. 1979;94(2):287\u201396.","journal-title":"Anal Biochem"},{"issue":"8","key":"295_CR44","doi-asserted-by":"publisher","first-page":"e23627","DOI":"10.1371\/journal.pone.0023627","volume":"6","author":"S Barrett","year":"2011","unstructured":"Barrett S, Mohr PG, Schmidt PM, McKimm-Breschkin JL. Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses. PLoS One. 2011;6(8):e23627.","journal-title":"PLoS One"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0295-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-015-0295-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0295-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0295-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:22:00Z","timestamp":1630581720000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-015-0295-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,22]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["295"],"URL":"https:\/\/doi.org\/10.1186\/s12985-015-0295-3","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,22]]},"assertion":[{"value":"23 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"67"}}